Sagimet Biosciences (SGMT) Enterprise Value (2023 - 2024)
Sagimet Biosciences has reported Enterprise Value over the past 2 years, most recently at -$152.5 million for Q3 2024.
- Quarterly results put Enterprise Value at -$152.5 million for Q3 2024, down 49.73% from a year ago — trailing twelve months through Sep 2024 was -$152.5 million (down 49.73% YoY), and the annual figure for FY2023 was -$94.9 million, changed.
- Enterprise Value for Q3 2024 was -$152.5 million at Sagimet Biosciences, up from -$166.4 million in the prior quarter.
- Over the last five years, Enterprise Value for SGMT hit a ceiling of -$18.5 million in Q2 2023 and a floor of -$193.7 million in Q1 2024.